Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows
February 22, 2021
The Pfizer Inc. and BioNTech SE COVID-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.
The vaccine, which was rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections, according to a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the work. The companies and Israel's Health Ministry worked together on the preliminary observational analysis, which has not yet been peer-reviewed.
The results, also reported in Der Spiegel, are the latest in a series of positive data to emerge out of Israel, which has given more COVID-19 vaccines per capita than anywhere else in the world. Nearly half of the population has had at least one dose of vaccine. Separately, Israeli authorities on Saturday said the Pfizer-BioNTech shot was 99% effective at preventing deaths from the virus.